Giuseppe Saglio at LeukO 2026: When CML Stops Responding, What Comes Next?
@cmlnet @icmlf
oncodaily.com/dialogues/gius…
Pacientes LMC retweeted
Congratulations to Prof. Suttorp, this year’s winner of the John Goldman Prize for lifetime contributions to CML. His work on pediatric CML has helped many children with CML all over the world. @icmlf #ESH2026 @ONealCancerUAB @uabmedicine @ASH_hematology @BloodPortfolio
Pacientes LMC retweeted
Heading to New Orleans for ASH? Join us the day before!
🔬 iCMLf Forum 2026: Promise to Practice
📅 Friday 11th December 2026, 12-2:30pm CT
📍 SpringHill Suites New Orleans Warehouse District, New Orleans
Register now: buff.ly/kreBsuq
Pacientes LMC retweeted
CLL Horizons 2026 | Barcelona 🧡
Powerful panel today on Global CLL Science Today: What Innovation Looks Like in High-, Middle-, and Low-Resource Settings.
Experts and advocates from around the world — including voices from Africa, Asia, Europe, and the Middle East — came together to discuss one critical reality: the science is advancing rapidly, but access is still not equal.
Innovation only matters if it reaches every patient, regardless of where they live.
Strength in Science. Power in Community.
This is what real progress looks like.
#CLLHZ26 #CLLHorizons2026 #CLLAN #CLL #AccessToCare #PatientAdvocacy #HealthEquity @HENZOKENYA @MwakichakoBecky – at Nairobi, Kenya
Pacientes LMC retweeted
Es #DiaMundialContraelDolor #WorldDayAgainstPain❤️
Estamos junto a las personas, cuya meta diaria, muchas veces, consiste en sentir un #dolor llevadero🙄
#Investigación, para evitar tanto sufrimiento.
Gr. @leo_veritas por tu actitud🤗
Nuestro logo hoy +🟥
Pacientes LMC retweeted
Great session at #MPNHZ26 on Best Practices and @Friends_Of_Max represented by Trustee Anil Nagpal talking about being the crucial bridge between patients and physicians
🤝 Stronger connections, better understanding!
Anil Nagpal 🇮🇳 from Friends of Max discusses bridging the gap between physicians and patients.
How can advocates help strengthen communication and build more collaborative relationships?
#MPNHZ26 #PatientVoice
Pacientes LMC retweeted
🔬 Per saber com podem protegir-nos del càncer i per què, primer necessitem investigar.
Marcos Malumbres i José A. Seoane, investigadors del VHIO que lideren projectes estretament relacionats amb la prevenció, van compartir amb la ciutadania la seva visió en las #VHIOTalks26.
➡️ linke.to/VHIOTalksPrevencion…
#VHIODivulga
Pacientes LMC retweeted
👏Enhorabona a la Dra.@QueraltSalas, guanyadora d’una beca #CaixaImpulse amb un projecte que estudia com l’exercici digital abans i després del trasplantament pot millorar la recuperació dels pacients. 🏃♀️
@hospitalclinic @CaixaResearch
Pacientes LMC retweeted
Day 2 at CLL Horizons 2026: turning knowledge into action! 🤝 Exploring Immune chalenges in CLL,biology of hope, advocacy workshops, and well-being. 🧡 #CLLHorizons2026 #CLL #CLLCommunity#PatientAdvocacy #StrengthInSciencePowerInCommunity
Pacientes LMC retweeted
🔍 Highlights from the ESH-iCMLf 28th Annual John Goldman Conference on Chronic myeloid leukemia: Biology and Therapy - Scientific Session: Clinical trials.
📄 Read the full session summary and key takeaways: buff.ly/425f2Gg
Pacientes LMC retweeted
We are recruiting for a motivated and accomplished lymphoma expert who wants to build a career at @ONealCancerUAB @uabmedicine, a great place to work, with great potential to grow and expand our clinical research. @ASH_hematology @BloodPortfolio Apply at: uab.peopleadmin.com/postings…
🌐 Mañana, 17 de octubre, es el Día Mundial contra el Dolor. Desde la #SEHH recordamos que el dolor también importa en Hematología.
🩸 Puede estar relacionado con la propia enfermedad o con sus tratamientos, y persistir incluso después de finalizarlos.
👉 Visibilizarlo es el primer paso para reconocerlo y atenderlo.
#DíaMundialContraElDolor #Hematología @IASPpain @Sedolor
Pacientes LMC retweeted
Missed the iCMLf Regional Discussion Group for South Asia on 9 September? Watch the recordings and revisit key takeaways:
▶️ Managing Resistance to Treatment: buff.ly/Uo6JeuU
▶️ Managing serious adverse events in chronic phase CML patients: buff.ly/ZIELrfm
Pacientes LMC retweeted
Join us online on October 19th for an expert webinar, featuring key insights from the ESH-iCMLf 28th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy.
🌍 Online
🔗 Check out the program and register now: buff.ly/DvToOFs
Pacientes LMC retweeted
Happy #NationalHispanicHeritageMonth from ASH! 🎉
ASH celebrates the remarkable contributions of Hispanic and Latino/a/x hematologists, researchers, and clinicians advancing research and care for people with blood disorders. 🩸
#Hematology
Pacientes LMC retweeted
🏃 What a fantastic Fun Run at the ESH-iCMLf 28th Annual John Goldman Conference on CML: Biology and Therapy. Together, we raised US $3,333! 🎉
A heartfelt thank you to everyone who ran, walked, cheered, and donated. Your support makes a real difference 💜
Pacientes LMC retweeted
the one and only Dr. Hüseyin Seymen Dobur (@SeymenFlame) who has graduated from our medical school this year, gave a great talk on the cognitive functions in patients with chronic myeloid leukemia under TKI therapy at the ESH-iCMLf CML Conference 🥰❤️🧿
I wish him and the other undergraduate students who participated in this study the very best in their future careers! ☺️🤗
#ESHCML2026 @icmlf
Pacientes LMC retweeted
🔍 Highlights from the ESH-iCMLf 28th Annual John Goldman Conference on Chronic myeloid leukemia: Biology and Therapy - Scientific Session: Immunology and stem cells.
📄 Read the full session summary and key takeaways: buff.ly/Ww6QUvW
Pacientes LMC retweeted
🔍 Highlights from the ESH-iCMLf 28th Annual John Goldman Conference on Chronic myeloid leukemia: Biology and Therapy - Scientific Session: Immunology and stem cells.
📄 Read the full session summary and key takeaways here: buff.ly/X5m3iC5
Pacientes LMC retweeted
🏆 Congratulations to Prof. Junia V. Melo, recipient of the 2026 iCMLf Janet Rowley Prize, presented today at #ESHCML2026.
In her keynote, CML: when BCR::ABL1 was just BCR-ABL, Junia took us through decades of discoveries that helped shape our understanding and treatment of CML.








































